Intelligent Bio Solutions Inc
Research Intelligent Bio Solutions Inc (INBS) on Bullrun: market cap USD 4.39M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerINBS
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryMedical Devices
- CurrencyUSD
- Market capUSD 4.39M
- Financial periodFY2026
- RevenueUSD 4.22M
- Revenue growth38.1%
- Net income-USD 12.43M
- Free cash flow-USD 12.05M
- Gross margin48.6%
Valuation Snapshot
latest market cap is USD 4.39M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | USD 4.22M | -USD 12.43M | -USD 12.05M | 48.6% | n/a | USD 3.99M | USD 1.82M | USD 5.51M |
| FY2025 | USD 3.05M | -USD 10.57M | -USD 9.91M | 40.8% | -2 | USD 1.02M | USD 281.81K | USD 3.00M |
| FY2024 | USD 3.11M | -USD 10.16M | -USD 9.79M | 45.8% | -6.38 | USD 6.30M | USD 871.44K | USD 8.33M |
| FY2023 | USD 1.26M | -USD 10.63M | -USD 7.88M | 26.0% | -127 | USD 1.54M | USD 1.34M | USD 3.80M |
| FY2022 | USD 437.15K | -USD 8.31M | -USD 3.74M | 0.0% | -11.33 | USD 8.24M | USD 0 | USD 6.62M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-12 | USD 4.39M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 9.14M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 6.73M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 29.52M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 3.65M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 21.35M | n/a | n/a | n/a |
About Intelligent Bio Solutions Inc
Intelligent Bio Solutions Inc., a medical technology company, focused on developing and delivering non-invasive testing, and screening solutions in Asia Pacific, the United States, the United Kingdom, and internationally. The company operates intelligent fingerprinting drug screening system, a platform to analyze fingerprint sweat analysis to detect drugs abuse; and biosensor platform. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Intelligent Bio Solutions Inc's market cap?
Intelligent Bio Solutions Inc's market capitalization is USD 4.39M.
What does Intelligent Bio Solutions Inc do?
Intelligent Bio Solutions Inc., a medical technology company, focused on developing and delivering non-invasive testing, and screening solutions in Asia Pacific, the United States, the United Kingdom, and internationally. The company operates intelligent fingerprinting drug screening system, a platform to analyze fingerprint sweat analysis to detect drugs abuse; and biosensor platform. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. Intelligent Bio Solutions Inc.